Form4insider filings, from the source

SEC Form 4 · accession 0001213900-18-012091

Karyopharm Therapeutics Inc. · KPTI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Chione Ltd
10% Owner
Period of report
Aug 30, 2018
Accepted (ET)
Sep 4, 2018 · 6:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001503802

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
COMMON STOCKF1,F2,F3,F4,F5Aug 30, 2018S200,000$20.9995D7,847,535D
COMMON STOCKF1,F2,F3,F4,F5Aug 31, 2018S11,468$21.0495D7,836,067D
COMMON STOCKF1,F2,F3,F4,F5Sep 4, 2018S40,000$20.6018D7,796,067D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

Exhibit Index Exhibit 24.1 - Power of Attorney, dated February 2, 2018, made by Marcin Czernik and Chione Limited in favor of Simon Prisk (previously filed) Exhibit 24.2 - Power of Attorney, dated February 2, 2018, made by Andreas Hadjimichael and Chione Limited in favor of Simon Prisk (previously filed) Exhibit 24.3 - Power of Attorney, dated February 2, 2018, made by George Hadjimichael and Chione Limited in favor of Simon Prisk (previously filed) Exhibit 24.4 - Power of Attorney, dated February 2, 2018, made by Wiaczeslaw Smolokowski in favor of Simon Prisk Exhibit (previously filed) 99.1 - Joint Filer Information (filed herewith) Exhibit 99.2 - Joint Filing Agreement (previously filed). All previously filed exhibits were filed with the Schedule 13G/A of the reporting persons, filed on February 14, 2018, except that the Joint Filing Agreement was filed with the Form 4 of the reporting persons, filed on July 18, 2018.